Taxonomy
- Domain: Bacteria
- Phylum: Firmicutes
- Class: Bacilli
- Order: Lactobacillales
- Family: Lactobacillaceae
- Genus: Pediococcus
- Species: Pediococcus acidilactici (Authority: (Willems 1905) Collins et al. 1994)
Morphology and Physiology
- Gram‑positive, coccoid cells that typically occur in pairs or tetrads.
- Non‑motile, non‑spore‑forming.
- Facultatively anaerobic; growth is optimal at 30 °C–37 °C, pH 5.0–6.5.
- Produces lactic acid as the primary metabolic end‑product via the homofermentative pathway; can also generate minor amounts of acetic acid, ethanol, and carbon dioxide.
Genomic Characteristics
- Genome size ranges from 1.8 to 2.1 Mb, with a G+C content of approximately 38–40 mol %.
- Contains genes encoding for the phosphoketolase pathway, carbohydrate transport systems (e.g., phosphotransferase system), and bacteriocin production.
Ecology and Natural Habitat
- Isolated from a variety of fermented foods (e.g., sausage, cheese, sauerkraut, sourdough), plant material, and animal gastrointestinal tracts.
- Tolerates moderate salt concentrations (up to 6 % NaCl) and can survive low‑pH environments, contributing to its suitability for food fermentations.
Industrial and Food‑Technology Applications
- Fermentation: Employed as a starter culture in the production of fermented sausages, cured meats, and certain dairy products to develop characteristic flavor, aroma, and texture.
- Biopreservation: Produces pediocin-like bacteriocins (e.g., pediocin PA‑1) that inhibit spoilage and pathogenic Gram‑positive bacteria such as Listeria monocytogenes and Staphylococcus aureus.
- Probiotic Use: Commercially marketed in dietary supplements and functional foods; studies have reported potential benefits including modulation of gut microbiota, enhancement of immune responses, and inhibition of gastrointestinal pathogens. Regulatory status in many countries is “Generally Recognized As Safe” (GRAS) or equivalent, pending strain‑specific safety assessments.
Safety and Regulatory Status
- No significant reports of pathogenicity in humans or animals.
- Strain‑specific evaluations are required for novel applications; standard safety assessments include absence of transferable antibiotic resistance genes and lack of virulence factors.
Research Highlights
- Genomic sequencing of multiple strains has identified plasmid‑encoded bacteriocin clusters and stress‑response genes that underlie robustness in industrial processes.
- In vitro and animal studies have demonstrated anti‑inflammatory effects and the capacity to attenuate colonization by enteric pathogens, though human clinical data remain limited.
References (selected)
- Collins, M. D., et al. (1994). "The phylogeny of the genus Pediococcus based on 16S rRNA sequences." International Journal of Systematic Bacteriology, 44(2), 247‑254.
- Sakanaka, S. et al. (2007). "Pediococcus acidilactici as a probiotic in fermented foods." Journal of Applied Microbiology, 103(5), 1869‑1878.
- Viglierchio, A., Bakhshi, A. (2020). "Bacteriocin production by Pediococcus acidilactici and its application in food preservation." Food Microbiology, 92, 103‑111.
Note: The above synthesis is based on peer‑reviewed literature and authoritative taxonomic databases up to the knowledge cutoff of September 2021.